5 Proven Ways to Speed Up Your IRB Approval Process
For clinical researchers, time is one of the most valuable resources. Every day spent waiting for IRB approval translates to delayed patient enrollment, extended timelines, and increased study costs. While IRB review is a necessary and important safeguard that protects research participants, the approval process doesn't have to be a bottleneck.
Through working with thousands of research studies, we've identified specific strategies that consistently help researchers obtain faster IRB approval without compromising quality or compliance. Here are five proven ways to accelerate your IRB approval process.
1. Submit a Complete, High-Quality Application the First Time
The single most effective way to speed up IRB approval is to submit a thorough, well-prepared application from the start. Incomplete or poorly organized submissions inevitably lead to contingencies, requests for additional information, and multiple review cycles—each adding weeks to your timeline.
What Makes an Application Complete?
A complete IRB submission includes all required documents in the proper format:
- Protocol: Clear, detailed, and internally consistent
- Informed Consent Forms: Written at appropriate reading levels with all required elements
- Investigator Brochure or package insert: Current and comprehensive
- Recruitment materials: All versions, including social media content
- Case Report Forms (CRFs): Complete data collection instruments
- Curriculum vitae: For all key personnel
- Evidence of training: Current human subjects protection training certificates
- Site documents: Laboratory certifications, clinical licenses, regulatory approvals
Our comprehensive IRB submission requirements checklist provides a detailed roadmap for ensuring your application contains everything needed for efficient review.
Quality Over Speed
Researchers sometimes rush their initial submission in hopes of getting the review clock started, but this approach typically backfires. A submission with inconsistencies between the protocol and consent form, unclear safety monitoring procedures, or vague eligibility criteria will generate contingencies that delay final approval far more than taking extra time upfront to ensure quality.
Pro tip: Have a colleague or research coordinator review your submission with fresh eyes before submitting. They often catch gaps or inconsistencies that you've overlooked after working closely with the materials.
2. Determine if Your Study Qualifies for Expedited Review
Not all studies require full board review. Research involving no more than minimal risk and falling into specific regulatory categories may qualify for expedited review—a streamlined process that can reduce approval timelines from weeks to just days.
Understanding Expedited Categories
The federal regulations define specific categories of research eligible for expedited review, including:
- Collection of biological specimens by non-invasive means
- Collection of data through noninvasive procedures routinely employed in clinical practice
- Research on individual or group characteristics or behavior
- Studies involving materials that have been collected for non-research purposes
Many researchers are surprised to learn their studies qualify for this faster pathway. Our detailed guide on expedited IRB review explains the qualification criteria and application process.
The Time Savings
While full board review typically requires waiting until the next scheduled meeting (often monthly), expedited review can be completed by one or two IRB reviewers on a rolling basis. This can reduce approval times from 4-6 weeks to 1-2 weeks or even less.
Important caveat: Even if you believe your study qualifies for expedited review, the IRB makes the final determination. Clearly identify in your submission why you believe expedited review is appropriate, but be prepared for the possibility of full board review if the IRB disagrees.
3. Choose the Right IRB Partner for Your Study
The IRB you select significantly impacts your approval timeline. Different IRBs have varying areas of expertise, review processes, meeting schedules, and operational efficiencies.
Consider These Factors
Meeting Frequency: Some IRBs convene weekly, others monthly. For studies requiring full board review, this alone can mean the difference between a 1-week and 4-week wait.
Therapeutic Area Expertise: IRBs with experience in your specific research area can review protocols more efficiently because reviewers understand the standard procedures, typical risks, and regulatory requirements. An IRB that regularly reviews oncology trials, for example, will process your cancer study faster than one that rarely sees such protocols.
Technology and Communication: Modern IRBs use sophisticated platforms that provide real-time status updates, streamlined document submission, and efficient communication. This infrastructure significantly reduces administrative delays.
Dedicated Support: IRBs that assign experienced coordinators to guide you through the submission process help prevent common errors that cause delays.
For multi-site studies, the decision becomes even more critical. The single IRB mandate for NIH-funded research has made central IRB review the standard approach, and selecting an efficient central IRB can dramatically reduce both approval times and ongoing administrative burden.
Our guide on how to choose the right IRB for your clinical trial provides a comprehensive framework for making this important decision.
4. Respond Promptly and Thoroughly to Contingencies
Even with perfect preparation, IRBs may request clarifications or modifications. How quickly and effectively you respond to these contingencies directly impacts your final approval date.
Best Practices for Contingency Responses
Respond immediately: When you receive contingency requests, prioritize them. Every day you delay your response adds another day to the approval timeline.
Address every point: Create a point-by-point response document that addresses each IRB question or concern explicitly. Don't assume the IRB will infer your response from protocol changes—spell it out clearly.
Track changes: When revising documents, use track changes or provide a summary of modifications. This allows reviewers to quickly identify what changed rather than re-reading entire documents.
Don't argue unnecessarily: If an IRB request seems burdensome but doesn't compromise your study's scientific integrity, consider accepting it rather than debating. A lengthy back-and-forth defending your original approach may cost more time than implementing the requested change.
Ask for clarification: If you don't understand a contingency request, ask for clarification immediately rather than guessing. A misunderstood contingency leads to inadequate responses and additional review cycles.
Communication is Key
Establish a positive working relationship with your IRB coordinator. They can often provide insight into reviewer concerns, suggest efficient ways to address contingencies, and answer questions that prevent submission errors.
5. Prepare Your Study Team Before Submission
IRB approval isn't just about the protocol review—it's also about ensuring all personnel are qualified and properly trained. Delays in obtaining personnel documentation can hold up approval even when the protocol itself is ready.
Personnel Preparation Checklist
Training completion: Ensure all investigators and key personnel have current human subjects protection training before submission. Some IRBs accept CITI, NIH, or other programs—verify requirements in advance.
Curriculum vitae: Collect updated CVs that demonstrate relevant qualifications and experience for each team member's role.
Medical licenses: For clinical sites, obtain current medical licenses and clinical privileges documentation.
Financial disclosure: Complete conflict of interest disclosures for all investigators.
Delegation of authority: Prepare delegation logs that clearly identify each team member's responsibilities.
Site Readiness
For clinical trials, verify that your site has necessary resources before IRB submission:
- Laboratory certifications (CLIA, CAP, etc.)
- Pharmacy credentials and drug storage capabilities
- Equipment calibration and maintenance records
- Emergency equipment and procedures
- Space and facilities appropriate for the research
Submitting before these elements are in place may result in conditional approval that you cannot activate, effectively negating any time saved.
Common Mistakes That Slow Down Approval
Avoiding these frequent pitfalls can prevent unnecessary delays:
Inconsistent information: Discrepancies between the protocol, consent form, and other documents trigger contingencies. Cross-check all documents for consistency.
Inadequate safety monitoring: Vague descriptions of adverse event monitoring and reporting procedures raise red flags. Be specific about who monitors safety, how often, and what triggers reports.
Poorly written consent forms: Consent documents written above the 8th-grade reading level or missing required elements need revision. Use readability tools and templates.
Missing regulatory approvals: Submitting before obtaining necessary FDA IND/IDE approvals, DEA licenses for controlled substances, or other regulatory requirements.
For a comprehensive look at what causes IRB rejections and delays, see our guide on common reasons IRB applications get rejected.
The Bottom Line: Planning Prevents Delays
While there's no shortcut that bypasses necessary ethical review, strategic planning and thoughtful preparation can significantly reduce your IRB approval timeline. The most successful researchers:
- Invest time in thorough preparation before submission
- Select IRB partners aligned with their research needs
- Maintain open communication with their IRB throughout the review process
- Learn from each submission to improve future applications
Remember that speed should never come at the expense of participant protection or regulatory compliance. The goal is efficient review, not rushed review. By implementing these five strategies, you can accelerate your approval timeline while maintaining the highest standards of research ethics.
How Elemental IRB Can Help
At Elemental IRB, we understand that your research timeline matters. Our streamlined review processes, therapeutic area expertise, and dedicated support team are designed to provide efficient, thorough ethical oversight without unnecessary delays. Whether you're conducting a single-site study or coordinating a complex multi-site trial, our team is ready to guide you through the approval process with clarity and speed.
Contact us today to learn how Elemental IRB can help you accelerate your research timeline while ensuring the highest standards of participant protection and regulatory compliance.